Genes · 2019 · 43 citations · 11 references
MedicineOncologyPharmacologyCancer PharmacologyCell SignalingMolecular OncologyColorectal CancerProbioticsAnti-proliferative SignalingCell Cycle Arrest MechanismsCell Cycle Arrest SignalingCell Cycle InhibitionG2 Phase ProgressionP21 PathwayProbiotic FunctionalityTherapeutic Efficacy Assessment
Recently, we reported a novel therapeutic probiotic-derived protein, p8, which has anti-colorectal cancer (anti-CRC) properties. In vitro experiments using a CRC cell line (DLD-1), anti-proliferation activity (about 20%) did not improve after increasing the dose of recombinant-p8 (r-p8) to >10 μM. Here, we show that this was due to the low penetrative efficiency of r-p8 exogenous treatment. Furthermore, we found that r-p8 entered the cytosol through endocytosis, which might be a reason for the low penetration efficiency. Therefore, to improve the therapeutic efficacy of p8, we tried to improve delivery to CRC cells. This resulted in endogenous expression of p8 and increased the anti-proliferative effects by up to 2-fold compared with the exogenous treatment (40 μM). Anti-migration activity also increased markedly. Furthermore, we found that the anti-proliferation activity of p8 was mediated by inhibition of the p53-p21-Cyclin B1/Cdk1 signal pathway, resulting in growth arrest at the G2 phase of the cell cycle. Taken together, these results suggest that p8 is toxic to cancer cells, shows stable expression within cells, and shows strong cancer suppressive activity by inducing cell cycle arrest. Therefore, p8 is a strong candidate for gene therapy if it can be loaded onto cancer-specific viruses.
11
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Genetic Alterations during Colorectal-Tumor Development
Bert Vogelstein, Eric R. Fearon, Stanley R. Hamilton et al. · New England Journal of Medicine · 1988 · 6.8K citations
Steven A. Rosenberg, Paul Aebersold, Kenneth Cornetta et al. · New England Journal of Medicine · 1990 · 1.3K citations · Full text
Medicine, Immunology, Oncology +16
China approves first gene therapy
Sue Pearson, Hepeng Jia, Keiko Kandachi · Nature Biotechnology · 2004 · 252 citations · Full text
Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis
Ling Zhang, Xiaoyang Ren, Eckhard Alt et al. · Nature · 2010 · 140 citations